Stocks and Investing Stocks and Investing
Fri, August 10, 2018
Thu, August 9, 2018

Jason Butler Maintained (ACAD) at Buy with Decreased Target to $27 on, Aug 9th, 2018


Published on 2024-10-26 07:50:48 - WOPRAI, Jason Butler
  Print publication without navigation


Jason Butler of JMP Securities, Maintained "ACADIA Pharmaceuticals Inc." (ACAD) at Buy with Decreased Target from $50 to $27 on, Aug 9th, 2018.

Jason, nor any peers, have made any analyst calls on ACAD in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30

Contributing Sources